French company: Anticontour vaccines for everyone, America has priority

French pharmaceutical giant SANOFI plans that the vaccine against the coronary is available to all and that the United States of America would have priority because they were the first to finance the company. “Vaxin vs COVID-19 will be made available to the entire public, regardless of nationality”, said company director general Paul [...]
“Vaxin vs COVID-19 will be made available to the entire public, regardless of the nationality”, said company general director Paul Hudson.
The message came after, in an interview with”Bloomberg”, Hudson stressed that the United States of America would have priority because they were the first in financing the company.
The U.S. government has the right to the greatest order, since it risked investing”, Hudson declared for”Bloomberg”.
In April, SANOFI and the pharmaceutical company GlaxosSmithKline said they wanted to work together on developing an anti-commercial vaccine.












